Month: January 2022

Company announcement – No. 3 / 2022 Zealand Pharma Completes Enrollment in EASE-SBS 1 Phase 3 Trial Assessing Glepaglutide in Patients with Short Bowel SyndromeFull trial results of EASE-SBS 1 expected in the third quarter of 2022 Pending positive pivotal data, Zealand intends to file for marketing approval with the U.S. Food and Drug AdministrationCopenhagen, DK and Boston, MA, U.S. January   20, 2022 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, today announced completion of patient enrollment in its pivotal Phase 3 trial (EASE-SBS 1) of glepaglutide, the company’s long-acting GLP-2 analog, for the potential treatment of short bowel syndrome (SBS). Glepaglutide is being investigated for once or twice...

Integrates all boating and navigation functions into one sharp and bright touch display MONTREAL, Jan. 20, 2022 (GLOBE NEWSWIRE) — Vision Marine Technologies, Inc. (NASDAQ: VMAR) (“Vision Marine” or the “Company”), the global leader in the electric transition of the recreational boating industry serving both OEMs and consumers, has partnered with Nextfour Solutions Ltd. (Nextfour) to further develop a customized multifunctional display to be integrated within Vision Marine’s groundbreaking E-Motion™ 180 fully electric powertrain system. The Q Display is the first marine display that brings the familiar automotive-like user experience to boating by integrating the on-board computer, mobile connectivity, chart plotter, guard, and entertainment system in one single device. This smart navigation device, which is called the Q Experience,...

WALTHAM, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-selective immuno-oncology therapies for people living with cancer, today announced that the first patient has been dosed in the company’s Phase 1/2 clinical trial evaluating XTX202 for the treatment of solid tumors. XTX202 is a modified form of IL-2 that is designed to localize activity in the tumor microenvironment (TME), with the goal of overcoming the known tolerability challenges of existing IL-2 therapies while achieving enhanced anti-tumor activity. “We are pleased to begin patient dosing in our Phase 1/2 clinical trial with XTX202, a novel tumor selective IL-2 candidate with the potential to increase the therapeutic benefit of IL-2,” said Marty Huber, M.D., president of research and development...

Table 2: 2019 Marimaca Oxide Deposit Mineral Resource Estimate**CuT means total copper and CuS means acid soluble copper. Mineral resources that are not mineral reserves do not have demonstrated economic viability. Does not include primary sulphides. Refer to news release “Coro Announces Substantial Increase in Resources; Development Studies Underway” 2 December 2019. Technical and economic parameters included: copper price US$3.00/lb; mining cost US$2.00/t; HL processing cost including G&A US$9.00/t; ROM processing cost including G&A US$2.50/t; selling cost US$0.07/lb; heap leach recovery 76% of CuT; ROM recovery 40% of CuT; pit slope angle 44-46°.Figure 1Plan view of exploratory scout drilling program overlain on rock geochemistryVANCOUVER, British Columbia, Jan. 20, 2022 (GLOBE NEWSWIRE)...

NEW YORK, Jan. 20, 2022 (GLOBE NEWSWIRE) — Brooklyn ImmunoTherapeutics, Inc. (Nasdaq: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood disorders, and monogenic diseases, today announces the appointment of two new members of the Company’s Board of Directors. Erin S. Enright has served on multiple Boards of Directors, including within the medical and life sciences arenas, such as Keystone Dental (serving as Audit Committee Chair), Medical Facilities Corporation (serving as Audit and Investment Committee Chair), and Dynatronics Corporation (serving on the Audit, Compensation, Nominating and Governance Committees). She is currently managing partner and co-founder of Prettybrook Partners, LLC, an investment firm specializing...

DANVILLE, Va., Jan. 20, 2022 (GLOBE NEWSWIRE) — American National Bankshares Inc. (NASDAQ: AMNB) (“American National” or the “Company”) today reported fourth quarter 2021 earnings of $11.3 million, or $1.05 per diluted common share. Those results compare to $8.8 million, or $0.80 per diluted common share, during the same quarter in the prior year, and net income of $10.2 million, or $0.94 per diluted common share, recognized for the third quarter of 2021. Earnings for the twelve months ended December 31, 2021 were $43.5 million, or $4.00 per diluted common share, compared to $30.0 million, or $2.73 per diluted common share, for the same period of 2020. President and Chief Executive Officer, Jeffrey V. Haley, commented, “American National finished 2021 on a positive note with strong earnings for the fourth quarter and the full year....

CALGARY, Alberta, Jan. 20, 2022 (GLOBE NEWSWIRE) — (PIPE – TSX) Pipestone Energy Corp. (“Pipestone” or the “Company”) today announced it has achieved independent certification of all its production from its world class Pipestone Wembley asset under the Equitable Origin EO100™ Standard for Responsible Energy Development. The certified unit is in the Montney formation, located west of Grande Prairie, Alberta, covering more than 90,000 net acres. The company began the process of seeking independent certification through Equitable Origin in April 2021. The EO100™ Standard for Responsible Energy Development is a set of rigorous performance standards for energy development projects that was developed by the non-profit organization Equitable Origin. The EO100™ standard represents leading industry practices for site-level ESG performance...

BALTIMORE, Jan. 20, 2022 (GLOBE NEWSWIRE) — Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve, today announced the hiring of six new employees who will enhance Graybug’s Research & Development (R&D), Regulatory Affairs and Program Management capabilities, as the Company further builds momentum behind its pipeline in 2022. “We are at a critical stage in our efforts to further progress and diversify our pipeline with new, high-value programs. I strongly believe that strengthening our world-class ophthalmology team is key to our future success. I am therefore pleased to welcome several new team members, who add critical leadership in Regulatory Affairs and Program Management, as well as...

Program Open to the 35 State Problem Gambling Councils, with Councils Having Broad Discretion on How the Money is Best Allocated to Further Responsible Gaming BOSTON, Jan. 20, 2022 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) today announced a multi-year financial commitment to assist the state councils across the country providing critical funding which will support the work of local nonprofit organizations. As part of the new initiative, entitled The State Council Funding Program, DraftKings has offered each state council $15,000 per year for three years, a total overall commitment of $1,575,000 over the span of the three-year program. “Having spent several years of my career working with the state council in my home state, Massachusetts, I have seen first-hand how these organizations are a tremendous resource for individuals...

TORONTO, Jan. 20, 2022 (GLOBE NEWSWIRE) — Fox River Resources Corporation (the “Company” or “Fox River”) (CSE: FOX) is pleased to announce an update on its currently underway National Instrument (“NI”) 43-101 preliminary economic assessment (“PEA”) study on the Company’s 100% owned Martison Phosphate Project (“Martison”), located near Hearst, Ontario, Canada. The objectives of the PEA include:Completion of an independent PEA-level engineering analysis of the project with the aim of producing phosphate fertilizer products from a fully integrated facility; Providing an updated NI 43-101 mineral resource estimate; Providing an estimate of the potential economic value of the project; Providing an estimate of the project’s capital costs, operating costs, as well as sustaining capital costs; Providing a conceptual economic model...